From Proteomic Analysis to Clinical Significance
Shilei Ding,Yan Li,Ye Tan,Man Jiang,Bo Tian,Ying Kun Liu,Xiaofeng Shao,Sheng Long Ye,Jia Wu,Rong Zeng,Hong Yang Wang,Zhao You Tang,Qing Xia
DOI: https://doi.org/10.1074/mcp.m300094-mcp200
IF: 7.381
2004-01-01
Molecular & Cellular Proteomics
Abstract:To better understand the mechanism underlying the hepatocellular carcinoma (HCC) metastasis and to search potential markers for HCC prognosis, differential proteomic analysis on two well-established HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional gel electrophoresis followed by matrix-assisted laser desorption/time-of-flight mass spectrometry. Cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on 102 human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases (satellite nodules, p < 0.05; vascular tumor emboli, p < 0.001; tumor node metastatis staging, p < 0.001). CK19 fragment CYFRA 21-1 levels measured in sera from nude mice model of human HCC metastasis with radioimmunoassay increased in parallel with tumor progression and rose remarkably when pulmonary metastases occurred. The results demonstrated that overexpression of CK19 in HCC cells is related to metastatic behavior. Serum CK19 level might reflect the pathological progression in some HCC and may be a useful marker for predicting tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases. To better understand the mechanism underlying the hepatocellular carcinoma (HCC) metastasis and to search potential markers for HCC prognosis, differential proteomic analysis on two well-established HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional gel electrophoresis followed by matrix-assisted laser desorption/time-of-flight mass spectrometry. Cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on 102 human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases (satellite nodules, p < 0.05; vascular tumor emboli, p < 0.001; tumor node metastatis staging, p < 0.001). CK19 fragment CYFRA 21-1 levels measured in sera from nude mice model of human HCC metastasis with radioimmunoassay increased in parallel with tumor progression and rose remarkably when pulmonary metastases occurred. The results demonstrated that overexpression of CK19 in HCC cells is related to metastatic behavior. Serum CK19 level might reflect the pathological progression in some HCC and may be a useful marker for predicting tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases. Metastasis is the most life-threatening event in cancer patients. For hepatocellular carcinoma (HCC), 1The abbreviations used are: HCC, hepatocellular carcinoma; CK, cytokeratin; 2-DE, two-dimensional electrophoresis; IEF, isoelectric focusing; MALDI, matrix-assisted laser desorption/ionization; TOF, time-of-flight; MS, mass spectrometry; IF, intermediate filament; TNM, tumor node metastasis; AFP, α-fetoprotein.1The abbreviations used are: HCC, hepatocellular carcinoma; CK, cytokeratin; 2-DE, two-dimensional electrophoresis; IEF, isoelectric focusing; MALDI, matrix-assisted laser desorption/ionization; TOF, time-of-flight; MS, mass spectrometry; IF, intermediate filament; TNM, tumor node metastasis; AFP, α-fetoprotein. the fourtth leading cause of cancer death worldwide and the second in China, surgery remains the treatment of choice, but the 5-year recurrence rate after section is as high as 40–70% (1Tang Z.Y. Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence..Gastroenterol. Today. 2000; 4: 191-195Google Scholar). Metastatic recurrence is the main obstacle to the improvement of treatment efficacy. Pathologic factors indicative of tumor invasiveness such as portal vein invasion, intrahepatic metastasis, presence of satellite nodules, large tumor size, and advanced tumor node metastasis (TNM) stage, are the best-established risk factors for recurrence (2Qin X.L. Tang Z.Y. The prognostic significance of clinical and pathological features in hepatocellular carcinoma..World J. Gastroenterol. 2002; 8: 193-199Google Scholar). However, the molecular events promoting invasiveness of HCC cells are still hardly known and routine biomarkers for HCC prognosis are not yet available. For a better insight into the mechanisms of HCC metastasis, a high metastatic human HCC cell line, MHCC97, its clonal cells, MHCC97-H and MHCC97-L, with high and low metastatic potentials, and progressively more metastatic cells from lung metastatic lesions were established via repeated in vivo selection (3Tian J. Tang Z.Y. Ye S.L. Liu Y.K. Lin Z.Y. Chen J. Xue Q. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis..Br. J. Cancer. 1999; 81: 814-818Google Scholar, 4Li Y. Tang Z.Y. Ye S.L. Liu Y.K. Chen J. Xue Q. Chen J. Gao D.M. Bao W.H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97..World J. Gastroenterol. 2001; 7: 630-636Google Scholar, 5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). These cells provide appropriate model systems with similar genetic background for the comparative study on the molecular events involved in HCC metastasis. Among the currently available techniques, proteomics permits the analysis of thousands of modified or unmodified proteins simultaneously and becomes increasingly popular for identifying biomarkers for early detection, classification, and prognosis of tumors, as well as pinpointing targets for improved treatment outcomes (6Simpson R.J. Dorow D.S. Cancer proteomics: from signaling networks to tumor markers..Trends Biotech. 2001; 19: 40-48Abstract Full Text Full Text PDF Google Scholar). We had used this approach to identify differentially expressed proteins between human HCC and normal liver cell line and investigated malignant growth-associated proteins in human hepatoma cells transfected with antisense-epidermal growth factor receptor (7Yu L.R. Zeng R. Shao X.X. Wang N. Xu Y.H. Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry..Electrophoresis. 2000; 21: 3058-3068Google Scholar, 8Yu L.R. Shao X.X. Jiang W.L. Xu D. Chang Y.C. Xu Y.H. Xia Q.C. Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence..Electrophoresis. 2001; 22: 3001-3008Google Scholar). In this study, this technique was combined with immunology methods to study MHCC97-H and MHCC97-L for screening metastasis-associated proteins. Cytokeratins represent important structural components of the epithelial cytoskeleton, and their expression is remarkably tissue specific, suggesting that the type of cytokeratins present in the cells is related to their biological function (9Moll R. Franke W.W. Schiller D.L. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells..Cell. 1982; 31: 11-24Google Scholar). Recent studies have indicated that cytokeratins play an important role in the regulation of cell migration and invasion. The accumulation of cytokeratin 16 (CK16) correlated with a re-organization of keratin filaments to a perinuclear position away from the direction of migration as a prerequisite for cell migration into the wound site (10Paladini R.D. Takahashi K. Bravo N.S. Coulombe P.A. Onset of reepithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16..J. Cell Biol. 1996; 132: 381-397Google Scholar). Cell transfected with human cytokeratin 8 (CK8) and cytokeratin 18 (CK18) had higher migratory and invasive abilities (11Chu Y.W. Runyan R.B. Oshima R.G. Hendrix M.J. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion..Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 4261-4265Google Scholar). Direct evidence has been provided to link overexpression of cytokeratins in human melanoma with increased migratory and invasive activity in vitro (12Hendrix M.J. Seftor E.A. Chu Y.W. Trevor K.T. Seftor R.E. Role of intermediate filaments in migration, invasion and metastasis..Cancer Metastasis Rev. 1996; 15: 507-525Google Scholar). The mechanism responsible for the differential expression of metastatic properties rests in the unique interaction, either direct or indirect, of cytokeratin intermediate filaments (IFs) with specific integrins interacting with the extracellular matrix (12Hendrix M.J. Seftor E.A. Chu Y.W. Trevor K.T. Seftor R.E. Role of intermediate filaments in migration, invasion and metastasis..Cancer Metastasis Rev. 1996; 15: 507-525Google Scholar, 13Crowe D.L. Milo G.E. Shuler C.F. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential..J. Dent. Res.,. 1999; 78: 1256-1263Google Scholar). Here cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L by proteomic approach. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases. Serum CK19 fragment CYFRA 21-1 levels in nude mice model demonstrated that CK19 might be a useful marker for predicting the possibility of tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases. MHCC97-H and MHCC97-L cells were established from the same parent cell line, MHCC97. After orthotopic inoculation of MHCC97-H and MHCC97-L to recipient nude mice, respectively, spontaneous pulmonary metastasis occurred in 100 and 40% (4Li Y. Tang Z.Y. Ye S.L. Liu Y.K. Chen J. Xue Q. Chen J. Gao D.M. Bao W.H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97..World J. Gastroenterol. 2001; 7: 630-636Google Scholar). A series of progressively more metastatic HCC cell strains designated as HCCLM1–5 were also established via repeated in vivo selection from MHCC97-H cells (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). These cells were cultured in Dulbecco’s modified Eagle’s medium (Life Technologies, Grand Island, NY) supplemented with 10% fetal calf serum (Hyclone, Logan, Utah) at 37 °C in 5% CO2. Sample preparation was performed as described previously (7Yu L.R. Zeng R. Shao X.X. Wang N. Xu Y.H. Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry..Electrophoresis. 2000; 21: 3058-3068Google Scholar). Protein concentrations were determined using modified Bradford assay (14Link A.J. 2-D Proteome Analysis Protocols. Humana Press, Totowa, NJ1999: 99-103Google Scholar). All samples were stored at −80 °C prior to electrophoresis. 2-DE was performed with the PROTEAN isoelectric focusing (IEF) system and PROTEAN xi II system (Bio-Rad, Hercules, CA) as previously described (7Yu L.R. Zeng R. Shao X.X. Wang N. Xu Y.H. Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry..Electrophoresis. 2000; 21: 3058-3068Google Scholar). Fifty micrograms of total proteins were run with an IEF system using 17-cm pH 3–10 ReadyStrip (Bio-Rad). The total Vh was 47,000∼52,000. SDS-PAGE was run at constant current of 10 mA for 30 min, and the current was switched to 25 mA till the bromphenol blue frontier reached the bottom of the gels. The proteins were detected with silver staining. For preparative 2-DE, 400 μg of proteins were separated by IEF as described above, and the total Vh was 90, 000∼120, 000. After electrophoresis in the second dimension, the gels were stained by a modified silver staining method compatible with mass spectrometry analysis (15Yan J.X. Wait R. Berkelman T Harry R.A. Westbrook J.A. Wheeler C.H. Dunn M.J. A modified silver staining protocol for visualization of proteins compatible with matrix-assited laser desorption/ionization and electrospray ionization mass spectrometry..Electrophoresis. 2000; 21: 3666-3672Google Scholar). Gels were scanned using a GS-710 imaging densitometer (Bio-Rad) and analyzed by PDQuest software (Bio-Rad). Protein identification was performed as described previously (16Shevchenko A. Wilm M. Vorm O. Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels..Anal. Chem. 1996; 68: 850-858Google Scholar) with some modifications. Briefly, spots were cut out from the gels, destained for 20 min in 30 mm KCN/100 mm Na2S2O3 1:1 (v/v), and washed with Milli-Q water until the gels became clear. Background gel was cut out and used as a negative control. Then they were kept in 0.2 m NH4HCO3 for 20 min, lyophilized, and digested overnight in 12.5 ng trypsin/μL in 0.1 m NH4HCO3. The peptides were extracted three times by 50% acetonitrile with 0.1% trifluoroacetic acid and lyophilized. Then 0.5 μL of peptides was mixed with the α-cyano-4-hydroxycinnamic acid matrix (Sigma, St. Louis, MO), applied onto the target, air dried, and analyzed by Bruker REFLEX III MALDI-TOF mass spectrometer (Bruker-Franzen Analytik, Bremen, Germany). Protein identification using peptide mass fingerprint was performed by Mascot search (www.matrixscience.com; MatrixSicence Ltd, London, UK) against the NCBI nonredundant protein database. The species is Homo sapiens. The errors in peptide masses were in the range of 0.01–0.1%. One missed tryptic cleavage site per peptide was allowed during the search. Cysteines were carboamidomethylated, and methionines were considered as oxidation. Proteins matching more than four peptides and Mascot scores higher than 63 were considered significant (p < 0.05). Protein was separated by 10% SDS-PAGE or by 2-DE as described above and electroblotted to Immobilon-P membrane (Millipore, Bedford, MA). After treating with 5% fat-free dried milk in 1× TBST (25 mm Tris, pH 7.5, 150 mm NaCl, 0.05% Tween-20, and 0.001% thimerosal) for 1 h at room temperature, the membranes were incubated with mouse anti-human CK19 (1:1000 dilution; Dako, Glostrup, Denmark) for 1 h at room temperature, followed by horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. Actin was used as an internal positive control. Target proteins were detected by enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech, Piscataway, NJ). Triplicate cultures of MHCC97-H and MHCC97-L cell clones were washed in phosphate-buffered saline (pH 7.4) and fixed in methanol at −20 °C for 5 min. The cells were first incubated with mouse anti-human keratin 8, 18, and 19 primary antibodies (Dako) (1:100 dilution for CK8 and CK18, 1:50 dilution for CK19) for 30 min at 37 °C, then incubated with fluorescein isothiocyanate-conjugated anti-mouse IgG secondary antibody (1:300 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA) for 30 min at room temperature. The negative control was performed without adding primary antibody. The cells were washed in phosphate-buffered saline three times each for 3 min. The slides were sealed in glycerin, and CK expression and layout pattern was observed by fluorescent microscopy (Zeiss, Oberkochen, Germany) at 450-nm wavelength. One hundred two HCC specimens from 88 male and 14 female patients with an average age of 51 (range 26–72) were obtained from the Eastern Hepatobiliary Surgery Hospital in the period of May 2002 to July 2003. Ninety-two (90.2%) patients had serological evidence of hepatitis B virus infection. The α-fetoprotein (AFP) level was above 25 μg/liter in 77 cases (75.5%). Tumor size was smaller than 5 cm in 30 patients and larger than 5 cm in 72 patients. Eighty-two patients (80.4%) had complication of cirrhosis. There were 27 cases (26.5%) in TNM stage I (T1N0M0) and II (T2N0M0) and 75 (73.5%) in stage III (T3N0M0, T4N0M0 and T1–4N1M0) and IV (any T, any N and M1) (17Pollock R.E. Manual of Clinical Oncology, Wiley-Liss, New York2002: 166-167Google Scholar). Capsule invasion was found in 64 cases, macroscopic portal vein tumor emboli in 9 patients, and microscopic surrounding liver vascular cancer emboli in 19 patients. Metastatic satellite nodules were found in 12 cases. After routine pathological study, these specimens were processed for immunohistochemical detection of CK19 expression with anti-CK19 primary antibody (1:500 dilution; Dako). The slides were lightly counterstained with Harris hematoxylin and viewed under a light microscope. Uninfected liver tissues from surgically resected hepatic cavernous hemangiomas were used as a negative control. Preoperative liver function tests were normal in all these patients and were negative for hepatitis B and C. An irrelevant primary antibody (pre-immune rabbit serum) was used to replace CK19 primary antibody on a consecutive section from CK19-positive staining followed by hematoxylin and eosin staining. CK19-positive staining was categorized as HCC-CK19+ if over 25% of the tumor cells were positively stained and as HCC-CK19− if stained otherwise. Highly spontaneous metastatic nude mice model of human HCC was used to study the relationship between serum CK19 fragment CYFRA 21-1 levels and tumor progression. A total of 5 × 106 cells/0.2 ml of HCCLM3 cell strain (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar) were injected subcutaneously into each of 30 4-wk-old male BALB/c-nu/nu nude mice obtained from the Shanghai Institute of Materia Medica, Chinese Academy of Science, and kept in specific pathogen-free facilities. It is more efficient to choose HCCLM3 cells for the establishment of the mouse model because it could produce prominent lung metastasis after subcutaneous injection (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). After tumor cell inoculation, the mice were randomly divided into six groups of five mice in each group. At the end of the second, third, fourth, fifth, sixth, and seventh week, one group of mice was sacrificed respectively under deep anesthesia by peritoneal injection of 3% phenobarbital chloride. The blood was drawn and centrifuged at 10,000 × g at 4 °C for 10 min to separate the serum and then kept at −80 °C. The tumor weight of each mouse was recorded. The lungs were fixed in 10% neutral formalin solution and processed for conventional pathological study. Pulmonary metastasis was recorded according to the procedures used before (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar). Serum CYFRA 21-1 levels in nude mice model of human HCC were determined by radioimmunoassay using a commercial detection kit (ELISA-CYFRA 21-1; CIS Bio International, Gif-Sur-Yvette, France) in accordance with the protocols. Student’s t test and Fisher’s exact test were used to compare the clinicopathologic parameters between HCC-CK19+ and HCC-CK19− groups for age, hepatitis B antigen, tumor size, serum AFP level, TNM stage, capsule invasion, metastatic satellite nodules, and blood vessel emboli. Values of p < 0.05 were considered statistically significant. For the comparison of serum CK19 levels in different animal groups, analysis of variance and q test was used. From cell culture to 2-DE, the experiments were repeated three times and silver-stained gels were analyzed by PDQuest software. The average protein spots detected were 1030 ± 113 in MHCC97-H and 1007 ± 107 in MHCC97-L. The scatter plots showed good correlation between these two kinds of cells with a correlation coefficient of 0.81, implying similarity in expression of most proteins and differences of only a small number of proteins between them (18Ding S.J. Li Y. Shao X.X. Zhou H. Zeng R. Tang Z.Y. Xia Q.C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.Proteomics. 2004; (in press)Google Scholar). A representative gel image was selected from MHCC97-L (Fig. 1 A). In total, 69 spots (including both housekeeping and differentially expressed proteins) were identified on the preparative silver-stained gels using MALDI-TOF-MS analysis (18Ding S.J. Li Y. Shao X.X. Zhou H. Zeng R. Tang Z.Y. Xia Q.C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.Proteomics. 2004; (in press)Google Scholar). Some of the identified proteins are shown in Fig. 1A. Among them, spot SSP 7615 was only present in MHCC97-H (Fig. 1B), and the MALDI-TOF mass spectrum of peptides derived from 7615 is shown in Fig. 1C. Mascot search using the peptide mass fingerprint data indicated that 18 peptides were matched with peptides from CK19, giving sequence coverage of 50% and a summary score of 240. Such results suggested that CK19 was the identity of spot 7615 with high confidence. CK8 and CK18 were also identified in MHCC97-H and MHCC97-L cells but without significant changes. To confirm the above proteomic result, we employed two-dimensional Western blot, which has the advantage of enhanced sensitivity and the ability to detect protein isoforms assigned from post-translational modifications. A trace amount of CK19 isoforms in MHCC97-L was detected, but its expression was much higher in MHCC97-H (Fig. 2 ). Furthermore, the immunofluorescene assay demonstrated that both MHCC97-H and MHCC97-L expressed CK8 and CK18 normally, with the same distribution and layout pattern, forming a well-extended filament network. However, the expression and distribution pattern of CK19 was quite different between these two kinds of cells, being well developed in MHCC97-H but almost invisible in MHCC97-L cells (Fig. 3 ).Fig. 3Immunofluorescence detection of CK IFs in MHCC97-H and MHCC97-L cells. A total of 1 × 104 cells were cultured on slide chamber for 24 h, washed, fixed, and treated with monoclonal antibodies against CK8, CK18, and CK19, followed by fluorescein isothiocyanate-conjugated secondary antibody, and viewed by immunofluorescent microscopy (1000×). The negative control was performed without adding primary antibody. Both CK8 and CK18, which are positive in HCC, were well developed in MHCC97-H and MHCC97-L, forming fine network pattern. In contrast, CK19 was aberrantly expressed in MHCC97-H but invisible in MHCC97-L cells.View Large Image Figure ViewerDownload (PPT) HCCLM1-5 cells, with progressively higher metastatic potential obtained from successive lung metastasis selections of MHCC97-H (5Li Y. Tang Z.Y. Ye S.L. Lilu B.B. Liu Y.K. Chen J. Xue Q. Establishment of human hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray..J. Cancer Res. Clin. Oncol. 2003; 129: 43-51Google Scholar), were examined for CK19 expression. As indicated in Fig. 4 , CK19 showed consistently increased expression from HCCLM1 to HCCLM5, suggesting a positive correlation of CK19 expression with their metastatic potentials. We further studied the CK19 expression in clinical HCC tissues using immunohistochemistry analysis. Among 102 HCC specimens, CK19 was positive in 12.7% (13/102) of the cases. When the CK19-positive group was compared with the CK19-negative group, more patients had poor tumor differentiation (grade III/IV tumors 13/13 (100.0%) versus 62/89 (69.7%), p < 0.001) and intrahepatic metastases (satellite nodules 5/13 (38.5%) versus 7/89 (7.9%), p < 0.05; tumor emboli in blood vessels 11/13 (84.6%) versus 17/89 (19.1%), p < 0.001). There was no significant correlation between CK19 expression with age, tumor size, and hepatitis B antigen seropositivity (p > 0.05) (Fig. 5 , Table I ).Table IRelationship between CK19 expression in tissue samples and clinicopathological characteristics of 102 HCC patientsCK19 positive (n = 13)CK19 negative (n = 89)p valueAge (years, median)54.749.9>0.05aStudent’s t test.HBsAgbHepatitis B surface antigen. positive92.3% (12/13)89.9% (80/89)>0.05cFisher’s exact test.Tumor size>5 cm69.2% (9/13)70.8% (63/89)≤5 cm30.8% (4/13)29.2% (26/89)>0.05cFisher’s exact test.AFP (>25 μg/liter)69.2% (9/13)76.4% (68/89)>0.05cFisher’s exact test.TNM stagingIII/IV100.0% (13/13)69.7% (62/89)I/II0.0% (0/13)30.3% (27/89)<0.001cFisher’s exact test.Capsule invasion61.5% (8/13)62.9% (56/89)>0.05cFisher’s exact test.Satellite nodules38.5% (5/13)7.9% (7/89)<0.05cFisher’s exact test.Vascular tumor embolidIncluding tumor emboli in the portal vein and small blood vessels.84.6% (11/13)19.1% (17/89)<0.001cFisher’s exact test.a Student’s t test.b Hepatitis B surface antigen.c Fisher’s exact test.d Including tumor emboli in the portal vein and small blood vessels. Open table in a new tab When the human HCC cell line HCCLM3 was injected into nude mice, tumors developed after 1 wk, showing aggressive growth. The tumor growth became accelerated from the third week on, and on the fifth week the mice showed signs of distress. Histopathological study of the lungs showed conspicuous metastases (Fig. 6 ). Tumor growth, lung metastasis, and serum CYFRA 21-1 levels are shown in Table II . The animal serum CYFRA 21-1 level increased in parallel with the progression of the engrafted tumor. Moreover, serum CYFRA 21-1 levels rose remarkably when pulmonary metastasis occurred (q test, p < 0.01).Table IIRelationship between serum CK19 level and lung metastasis in a nude mice modelWeek 2Week 3Week 4Week 5Week 6Week 7Tumor weight (g)0.31 ± 0.130.61 ± 0.121.43 ± 0.372.38 ± 0.923.74 ± 0.964.85 ± 1.02Lung metastasis rate (%)0020100100100Median no. of lung metastases000aOnly one mouse had lung metastases at week 4, and the total number of lung metastases was less than five, so the median number of lung metastases was 0.81118150Serum CK19 (μg/liter)4.79 ± 1.165.06 ± 1.218.55 ± 1.2540.71 ± 9.87bp < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test).76.29 ± 20.00bp < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test).95.94 ± 19.68bp < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test).a Only one mouse had lung metastases at week 4, and the total number of lung metastases was less than five, so the median number of lung metastases was 0.b p < 0.01, compared with serum CK19 level in week 4 (analysis of variance and q test). Open table in a new tab A great deal of effort has been made to predict HCC behavior, but specific prognostic indicators are still lacking. Prognostic factors in HCC conventionally consist of staging with the TNM system and grading by tumor cellular differentiation (19Qin L.X. Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma.World J. Gastroenterol. 2002; 8: 385-392Scopus (290) Google Scholar). There are also other factors useful in prognosis but most of them are clinical. A large number of molecular biological factors have been shown to associate with the invasiveness of HCC and have potential prognostic significance including proliferating cell nuclear antigen, Ki-67, E-cadherin, catenins, urokinase-type plasminogen activator (uPA), uPA receptor, vascular endothelial growth factor, and AFP, etc (19Qin L.X. Tang Z.Y. The prognostic molecular markers in hepatocellular carcinoma.World J. Gastroenterol. 2002; 8: 385-392Scopus (290) Google Scholar, 20Weber J.C. Nakano H. Bachellier P. Oussoultzoglou E. Inoue K. Shimura H. Wolf P. Chenard-Neu M.P. Jaeck D. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metast
What problem does this paper attempt to address?
-
From Proteomic Analysis to Clinical Significance: Overexpression of Cytokeratin 19 Correlates with Hepatocellular Carcinoma Metastasis
Sj Ding,Y Li,Yx Tan,Mr Jiang,B Tian,Yk Liu,Xx Shao,Sl Ye,Jr Wu,R Zeng,Hy Wang,Zy Tang,Qc Xia
DOI: https://doi.org/10.1074/mcp.m300094-mcp200
IF: 7.381
2004-01-01
Molecular & Cellular Proteomics
Abstract:To better understand the mechanism underlying the hepatocellular carcinoma (HCC) metastasis and to search potential markers for HCC prognosis, differential proteomic analysis on two well-established HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional gel electrophoresis followed by matrix-assisted laser desorption/time-of-flight mass spectrometry. Cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on 102 human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases ( satellite nodules, p < 0.05; vascular tumor emboli, p < 0.001; tumor node metastatis staging, p < 0.001). CK19 fragment CYFRA 21-1 levels measured in sera from nude mice model of human HCC metastasis with radioimmunoassay increased in parallel with tumor progression and rose remarkably when pulmonary metastases occurred. The results demonstrated that overexpression of CK19 in HCC cells is related to metastatic behavior. Serum CK19 level might reflect the pathological progression in some HCC and may be a useful marker for predicting tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases.
-
Proteome Analysis of Hepatocellular Carcinoma Cell Strains, MHCC97-H and MHCC97-L, with Different Metastasis Potentials.
SJ Ding,Y Li,XX Shao,H Zhou,R Zeng,ZY Tang,QC Xia
DOI: https://doi.org/10.1002/pmic.200300653
2004-01-01
PROTEOMICS
Abstract:To better understand the mechanism underlying hepatocellular carcinoma (HCC) metastasis and to search for potential markers for HCC prognosis, differential proteome analysis on two HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional (2-D) gel electrophoresis followed by matrix-assisted laser desorption/time of flight mass spectrometry and liquid chromatography ion trap mass spectrometry. Image analysis of silver-stained 2-D gels revealed that 56 protein spots showed significant differential expression in MHCC97-H and MHCC97-L cells (Student's t-test, P < 0.05) and 4 protein spots were only detected in MHCC97-H cells. Fourteen protein spots were further identified using in-gel tryptic digestion, peptide mass fingerprinting and tandem mass spectrometry. The expressions of pyruvate kinase M2, ubiquitin carboxy-terminal hydrolase L1, laminin receptor 67 kDa, S100 calcium-binding protein A4, thioredoxin and cytokeratin 19 were elevated in MHCC97-H cells. However, manganese superoxide dismutase, calreticulin precursor, cathepsin D, lactate dehydrogenase B, non-metastatic cell protein 1, cofilin 1 and calumenin precursor were down-regulated in MHCC97-H cells. Intriguingly, most of these identified proteins have been reported to be associated with tumor metastasis. The functional implications of alterations in the levels of these proteins are discussed.
-
[Study on the Relationship Between Serum Cytokeratin 19 Level in Hepatocellular Carcinoma Patients and the Clinico-Pathologic Characteristics].
Yan Li,Zhao-you Tang,Bo Tian,Lun-xiu Qin,Sheng-long Ye,Rui-xia Sun
DOI: https://doi.org/10.3760/j.issn:1007-3418.2004.06.008
2004-01-01
Abstract:OBJECTIVE:As our previous comparative proteomics study on high and low metastasis human hepatocellular carcinoma (HCC) cell strains revealed that cytokeratin 19 (CK19) was related to higher metastasis potential, we further investigated the relationship between serum CK19 level in HCC patients and their clinico-pathologic characteristics.METHODS:Serum CK19 levels of 101 normal controls and 108 pathology-proven HCC patients were determined using radioimmunoassay, and the their correlation with clinico-pathologic parameters were studied.RESULTS:The upper limit of one-side 98% confidence interval of normal serum CK19 level was 2.3 microg/L. Among 108 HCC patients, 24 (22.2%) had increased serum CK19 level, ranging from 2.4 to 45.5 microg/L. There were 12 patients (11.1%) with increased CK19 level but normal AFP level. The percentage of poor differentiated tumor was higher in CK19 increased cases (37.5%, 9/24) than in CK19 normal cases (20.2%, 17/84). Moreover, the presence of portal vein tumor emboli was significantly higher in CK19 increased cases (25.0%, 6/24) than in CK19 normal cases (6.0%, 5/84). (Chi-square = 7.403, P < 0.01) In addition, the percentage of TNM stage III/IV tumor was significantly higher in CK19 increased patients (54.2%, 13/24) than in CK19 normal cases. (chi-square = 13.300, P < 0.005)CONCLUSION:Some HCC patients do have increased serum CK19 level, which could be related to portal vein tumor emboli, poor tumor differentiation and advanced tumor stages.
-
[Serum proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma]
Bin-sheng Fu,Wei Liu,Jian-wen Zhang,Tong Zhang,Hua Li,Gui-hua Chen
Abstract:Objective: To screen the serum proteins associated with the metastasis of hepatocellular carcinoma (HCC) using a comparative proteomic approach. Methods: The serum samples of HCC patients with the same disease background were divided into metastatic (n=20) and non-metastatic (n=20) groups. The proteins extracted from the patients and 20 normal subjects, after depletion of the highly abundant proteins, underwent two-dimensional gel electrophoresis (2-DE). Comparative analyses of the 2-DE protein patterns between the 3 groups were conducted using a computerized image analysis system. The proteins with statistically significant differential expression between the metastatic and non-metastatic patients were identified by mass spectrometry. Western blotting was performed to examine the differential expression of the candidate proteins. Results: Four protein spots were identified by mass spectrometry among the 12 differentially expressed protein spots in the serum samples of HCC patients with intrahepatic metastasis, and confirmed by searching in MASCOT database. Of the 4 proteins, cytokeratin 9 (CK9) was up-regulated by 2 folds, and inter-alpha (globulin) inhibitor H4, complement factor H-related protein 1 precursor (FHR-1), and apolipoprotein E were down-regulated by 2 folds. CK9 was found to be specifically over-expressed in the metastatic group in comparison with the non-metastatic group, as confirmed by Western blotting. Conclusion: The metastasis of HCC might be correlated to the specific variation of protein expression profiles. The overexpression of CK9 may play a crucial role in HCC metastasis, and can be used as a potential serum marker for predicting HCC metastasis.
-
Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.
Yanyan Yu,Huali Shen,Hongxiu Yu,Fan Zhong,Yang Zhang,Chen Zhang,Jian Zhao,Hong Li,Jie Chen,Yinkun Liu,Pengyuan Yang
DOI: https://doi.org/10.1039/c0mb00265h
2011-01-01
Molecular BioSystems
Abstract:Systematic proteomic studying of the mechanism of hepatocellular carcinoma (HCC) metastasis remains challenging. We performed comparative proteomic and pathway analysis of four human metastatic HCC cell lines to identify metastasis-associated proteins. These HCC cell lines had a similar genetic background but with an increasing potential of metastasis. Using a combination of two dimensional electrophoresis (2-DE) and MALDI-TOF mass spectrometry, a total of 125 proteins and their post-translational modification forms or isoforms were found to be differentially expressed in the cell lines. Among them, 29 were gradually up-regulated whereas 17 were down-regulated with increasing metastatic potential. Instead of a traditional single-gene readout, global bioinformatics analysis was carried out, which revealed that the glycolysis pathway was the most significantly enriched pathway. The heat shock proteins (HSPs) centered and NF-kappaB centered networks were also enriched in the result, which may imply the key function of inflaming on metastasis. Meanwhile, knockdown of HDGF, an up-regulated protein and a target of NF-kappaB, induced cell apoptosis in the metastatic HCC cells. This work provides a demonstration that a combination of bioinformatics and comparative proteomics can help in finding out potential biomarkers associated with HCC metastasis on the level of pathways.
-
Proteomic Analysis on Metastasis-Associated Proteins of Human Hepatocellular Carcinoma Tissues
Jie-Feng Cui,Yin-Kun Liu,Bo-Shen Pan,Hai-Yan Song,Yu Zhang,Rui-Xia Sun,Jie Chen,Ju-Tao Feng,Zhao-You Tang,Yan-Ling Yu,Hua-Li Shen,Peng-Yuan Yang
DOI: https://doi.org/10.1007/s00432-005-0044-x
2005-01-01
Journal of Cancer Research and Clinical Oncology
Abstract:Purpose: A comparative proteomic approach was used to identify and analyze proteins related to metastasis of hepatocellular carcinoma (HCC). Methods: Proteins extracted from 12 HCC tissue specimens (six with metastases and six without) were separated by two-dimensional gel electrophoresis (2-DE). The protein spots exhibiting statistical alternations between the two groups through computerized image analysis were then identified by mass spectrometry. In addition immunohistochemistry (IHC), Western blotting and RT-PCR were performed to verify the expression of certain candidate proteins. Results: 16 proteins including HSP27, S100A11, CK18 were annotated by mass spectrometry, relevant to chaperone function, cell mobility, cytoskeletal architecture, respectively. Most were previously unconnected with metastasis of HCC. Of these HSP27 was found overexpressed consistently in 2-DE patterns of all metastatic HCC tissues compared with nonmetastatic ones. IHC and Western blotting of HCC tissues confirmed this difference while RT-PCR did not. Conclusion: There are various proteins joined together in HCC metastasis. The overexpression of HSP27 may serve as a biomarker for early detection and therapeutic targets unique to the metastatic phenotype of HCC.
-
Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances
ZHOU Xinmu,XU Shaojie,CHEN Lirong
2013-01-01
Abstract:Objective: To investigate the expression of serum response factor(SRF),E-cadherin and βcatenin in hepatocellular carcinoma and its relation to clinicopathological characterisitics of the tumor and prognosis.Methods: Tissue microarray and immunohistochemical study(EnVision method) for SRF,E-cadherin and βcatenin was performed on tissue microarray which consisted of 182 cases of hepatocellular carcinoma,92 cases of adjacent non-neoplastic liver tissues.Results: In the hepatocellular carcinoma group 75.8% tumor samples expressed SRF,and the levels is significantly higher than that in surrounding liver tissue(21.7%,P<0.05).The expression of SRF was positively correlated with the TNM stage,tumor metastasis and recurrence(P<0.05).In the hepatocellular carcinoma group,aberrant expression of E-cadherin and β-catenin was 59.3% and 58.8% respectively,and these levels were higher than those in the adjacent non-neoplastic liver tissue group(30.4% and 26.1% P<0.05).Aberrant expression of E-cadherin andβ-catenin was related to vascular cancer embolus,the TNM stage,tumor metastasis and recurrence(P<0.05).The expression of SRF correlated with aberrant expression of E-cadherin and β-catenin in hepatocellular carcinoma.Conclusion: In hepatocellular carcinoma,the overexpression of SRF and the downregulated expression of E-cadherin and β-catenin may be important mechanisms for promoting the invasion and metastasis of hepatocellular carcinoma and may also play a key role in the occurrence and development of hepatocellular carcinoma.
-
Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection
Xin-Rong Yang,Yang Xu,Guo-Ming Shi,Jia Fan,Jian Zhou,Yuan Ji,Hui-Chuan Sun,Shuang-Jian Qiu,Bing Yu,Qiang Gao,Yi-Zhou He,Weng-Zhen Qin,Rong-Xin Chen,Guo-Huan Yang,Bing Wu,Qing Lu,Zhi-Quan Wu,Zhao-You Tang
DOI: https://doi.org/10.1158/1078-0432.ccr-07-4338
IF: 13.801
2008-01-01
Clinical Cancer Research
Abstract:PURPOSE:Cytokeratin 10 (CK10) was found to be expressed differently in human hepatocellular carcinoma (HCC) cell lines with different metastatic potentials in our previous research. The aim of this study was to assess the value of CK10 alone or in combination with cytokeratin 19 (CK19) in predicting tumor recurrence after curative resection in HCC patients.EXPERIMENTAL DESIGN:CK10 expression in stepwise metastatic HCC cell lines and tumor tissues from 50 HCC patients was investigated using immunofluorescence assay, quantitative real-time reverse transcription-PCR, and Western blot analyses. Tumor tissue microarrays of 300 HCC patients who underwent curative resection between 1997 and 2000 were used to detect the expressions of CK10 and CK19. Clinicopathologic data for these patients were evaluated. The prognostic significance was assessed using Kaplan-Meier survival estimates and log-rank tests.RESULTS:CK10 was overexpressed in the high metastatic HCC cell line and in tumor tissues of recurrent patients. Both univariate and multivariate analyses revealed that CK10 was a significant predictor for overall survival (OS) and disease-free survival, and that CK19 was a significant predictor for OS. CK10 expression was correlated with poor prognosis regardless of alpha-fetoprotein, tumor-node-metastasis stage, and vascular invasion. The 7-year OS and disease-free survival rates in CK10+ and/or CK19+ patients were 30.0% and 37.6%, respectively, which were significantly lower than that of CK10-/CK19- patients (56.1% and 60.0%, respectively; P < 0.001).CONCLUSION:CK10 is associated with HCC invasiveness. CK10 alone, or in combination with CK19, can be a novel predictor for poor prognosis of HCC patients after curative resection.
-
Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
Qian Zhang,Wanting Xing,Jie Zhang,Junwen Hu,Lunan Qi,Bangde Xiang
DOI: https://doi.org/10.2147/ott.s298576
IF: 4
2021-03-01
OncoTargets and Therapy
Abstract:PURPOSE: The purpose of this study was to elucidate the relationship between cytokeratin 19 (CK19) expression and levels of circulating tumor cells (CTCs) in preoperative peripheral blood of patients with hepatocellular carcinoma (HCC), and the potential influence of that relationship on prognosis.PATIENTS AND METHODS: CanPatrol™ CTC-enrichment technique and in situ hybridization (ISH) were used to enrich and classify CTCs undergoing the epithelial-mesenchymal transition (EMT) from blood samples of 105 HCC patients. CK19 immunohistochemistry staining was performed on HCC tissues and compared with demographic and clinical data.RESULTS: In total, 27 of 105 (25.7%) HCC patients were CK19-positive. CK19-positive patients had significantly lower median tumor-free survival (TFS) than CK19-negative patients (5 vs 10 months, P = 0.047). In total, 98 (93.3%) patients showed pre-surgery peripheral blood CTCs (range: 0-76, median: 6), and 57 of 105 (54.3%) patients displayed CTC counts ≥6. Furthermore, CK19-positive patients with CTC count ≥6 showed significantly higher percentage than CK19-negative ones (77.8% vs 46.2%, P = 0.004). CK19-positive patients showed a significantly higher proportion of mesenchymal CTCs among CTCs undergoing EMT than CK19-negative patients (mean rank: 62.28 vs 49.79, P = 0.046). We also found that CK19-positive patients with high CTC count showed significantly shorter median tumor-free survival than CK19-negative patients with low CTC count (5 vs 16 months, P = 0.039).CONCLUSION: High CTC count and high percentage of mesenchymal CTCs are closely related to the expression of CK19, which is associated with poor prognosis in HCC patients.
oncology,biotechnology & applied microbiology
-
New Human Hepatocellular Carcinoma (Hcc) Cell Line With Highly Metastatic Potential (Mhcc97) And Its Expressions Of The Factors Associated With Metastasis
J Tian,Zy Tang,Sl Ye,Yk Liu,Zy Lin,J Chen,Q Xue
DOI: https://doi.org/10.1038/sj.bjc.6690769
IF: 9.075
1999-01-01
British Journal of Cancer
Abstract:A new human hepatocellular carcinoma (HCC) cell line with a highly metastatic potential was established from subcutaneous xenograft of a metastatic model of human HCC in nude mice (LCI-D20) by means of alternating cell culture in vitro and growth in nude mice. The line, designated MHCC97, has been cultivated for 18 months and subcultured for more than 90 passages. The line was showed to be of human origin by karyotype analysis. The cells were either grown as compact colonies (in clusters) or as a monolayered sheet with about 31 h of population-doubling time, exhibited typical malignant epithelial in morphology and were positive for alpha-fetoprotein (AFP). Plow cytometric analysis or the cell DNA content showed an aneuploid pattern, and its index was 1.5 as compared to that of normal human peripheral blood lymphocytes. Karyotypic analyses of G- and C-banding techniques revealed that all cells presented chromosome abnormalities in number and structure. The number of cell line MHCC97 chromosome ranged from 59 to 65 with a modal number of 60 and 61. At least two common chromosome markers, i(1q) and der(4)t(4;?)(4pter-->q35::?), were present in all cells, and deletion of Y chromosome also occurred in all cells. The subcutaneous and intrahepatic xenografts were formed and metastatic lesions in lungs were found after the cells were inoculated into nude mice. The rate of metastasis to lungs was 100% using orthotopic inoculation. Reverse transcription polymerase chain reaction products revealed positive expressions of integrin alpha(5) and beta(1), urokinase type plasminogen activator receptor (uPAR), vascular endothelial growth factor and nm23-H1 mRNAs of cell line MHCC97. Immunostaining of c-Met, uPAR showed strongly positive in both subcutaneous xenografts and lung metastatic lesions; while positive in xenografts and negative in metastatic lesions for integrin alpha(5), beta(1). E-cadherin and P53 was not expressed either in xenograft or in the metastatic lesions. PCR products of HBsAg and HBxAS were both positive. The cell line MHCC97 still retained some characteristic features of original tumour. Establishment of cell line MHCC97 should be beneficial to the studies of HCG metastatic mechanisms. (C) 1999 Cancer Research Campaign.
-
Identification and Analysis of Altered Alpha 1,6-Fucosylated Glycoproteins Associated with Hepatocellular Carcinoma Metastasis
Zhi Dai,Yin-Kun Liu,Jie-Feng Cui,Hua-Li Shen,Jie Chen,Rui-Xia Sun,Yu Zhang,Xin-Wen Zhou,Peng-Yuan Yang,Zhao-You Tang
DOI: https://doi.org/10.1002/pmic.200500707
2006-01-01
PROTEOMICS
Abstract:Tumor metastasis might be associated with the expression levels of cellular glycoproteins and the alteration of their glycan parts. In order to screen the aberrantly alpha 1,6-fucosylated glycoproteins related to hepatocellular carcinoma (HCC) metastasis, a high-throughput glycomic approach which consisted of 2-DE, electronic transfer of proteins, lectin affinity blot and precipitation, and MALDI-TOF-MS/MS, was established. Lens culinaris agglutinin (LCA) affinity glycoprotein profiles of higher and lower metastatic HCC cell lines were compared and analyzed. Seven out of 34 identified glycoproteins were differentially displayed; they were cytokeratin 8 (CK8), annexin I, annexin 11, heterogeneous nuclear ribonucleoprotein A/B, PDZ and LIM domain 1, RNA-binding motif protein 4, and poly(rC)-binding protein 1. On comparison with Hep3B, CK8 showed a higher affinity to Ricinus communis agglutinin 1 (RCA-1) and LCA, and annexin I presented a higher affinity to LCA and Con A by the lectin-binding assay. Furthermore, the up-regulation of CK8, annexin I, and annexin II were found by Western blot and immunofluorescence analysis in higher metastatic HCC cell lines. This implied that the alteration of CK8, annexin I, and annexin II both in their expression levels and their glycan parts might be related to metastatic ability, and play a critical role in the process of HCC metastasis.
-
Clinicopathological Characters and Prognostic Significance of Cytokeratins Expression in Intrahepatic Cholangiocarcinoma.
Q. Zhu,X. Yang,Y. Xu,J. Fan
DOI: https://doi.org/10.1200/jco.2011.29.15_suppl.e14667
IF: 45.3
2011-01-01
Journal of Clinical Oncology
Abstract:e14667 Background: The prognosis is unsatisfactory and can hardly be predicted for those patients with intrahepatic cholangiocarcinoma (ICC) underwent hepatectomy. The aim of this study is to investigate the prognostic values of glandular epithelia related cytokeratin 7 (CK7), cytokeratin 8 (CK8), cytokeratin 18 (CK18), and cytokeratin 19 (CK19) and their relations with clinicopathological characteristics in ICC patients. METHODS Tumor tissue microarrays (TMAs) of 162 ICC patients who underwent curative resection between 2001 and 2006 were used to detect the expressions of CK7, CK8, CK18 and CK19. The prognostic significance was assessed using Kaplan-Meier survival estimates and log-rank tests. Clinicopathologic data for these patients were evaluated. RESULTS The strong expression percentage for these four cytokeratins in 162 ICC patients was 79.0% (CK7), 51.2% (CK8), 76.5% (CK18), and 68.5% (CK19). The expression of CK7 was found to be associated with hepatitis B surface antigen (HBsAg) and alpha-fetoprotein (AFP) while CK19 was associated with HBsAg, carcinoembryonic antigen (CEA), gammaglutamyl transferase (GGT), carbohydrate antigen 19-9 (CA19-9) and tumor size. Tumor staging was linked with the expression of CK7, CK8 and CK18 except CK19. Both univariate and multivariate analyses revealed that CK18 and CK19 were significant predictors for overall survival (OS). CK19 strong expression and CK18 weak expression were correlated with poor prognosis regardless of tumor size, tumor encapsulation and perihila lymph node involvement. The OS rate in CK19strong and CK19weak patients were 16.2% and 39.2 % (P<0.005). The OS rate in CK18strong and CK18weak patients were 28.2% and 7.9% (P<0.001). CK19 combined with CK18 still related with OS. The OS rate in CK19strongCK18weak patients was 7.1%, which was significantly lower than that of CK19weakCK18strong patients (46.3%, P<0.001). CONCLUSIONS CK18 and CK19 can be used as novel predictors for the prognosis of ICC.
-
Bioinformatics Analysis of Metastasis-Related Proteins in Hepatocellular Carcinoma
Pei-Ming Song,Yang Zhang,Yu-Fei He,Hui-Min Bao,Jian-Hua Luo,Yin-Kun Liu,Peng-Yuan Yang,Xian Chen
DOI: https://doi.org/10.3748/wjg.14.5816
2008-01-01
Abstract:AIM: To analyze the metastasis-related proteins in hepatocellular carcinoma (HCC) and discover the biomarker candidates for diagnosis and therapeutic intervention of HCC metastasis with bioinformatics tools.METHODS: Metastasis-related proteins were determined by stable isotope labeling and MS analysis and analyzed with bioinformatics resources, including Phobius, Kyoto encyclopedia of genes and genomes (KEGG), online mendelian inheritance in man (OMIM) and human protein reference database (HPRD).RESULTS: All the metastasis-related proteins were linked to 83 pathways in KEGG, including MAPK and p53 signal pathways. Protein-protein interaction network showed that all the metastasis-related proteins were categorized into 19 function groups, including cell cycle, apoptosis and signal transduction. OMIM analysis linked these proteins to 186 OMIM entries.CONCLUSION: Metastasis-related proteins provide HCC cells with biological advantages in cell proliferation, migration and angiogenesis, and facilitate metastasis of HCC cells. The bird's eye view can reveal a global characteristic of metastasis-related proteins and many differentially expressed proteins can be identified as candidates for diagnosis and treatment of HCC. (C) 2008 The WIG Press. All rights reserved.
-
Serum CYFRA 21-1 Level Reflects Hepatocellular Carcinoma Metastasis: Study in Nude Mice Model and Clinical Patients
Yan Li,Zhao-You Tang,Bo Tian,Sheng-Long Ye,Lun-Xiu Qin,Qiong Xue,Rui-Xia Sun
DOI: https://doi.org/10.1007/s00432-006-0098-4
2006-01-01
Journal of Cancer Research and Clinical Oncology
Abstract:Our previous proteomics study on human hepatocellular carcinoma (HCC) cell strains revealed that cytokeratin 19 (CK19) was expressed in cells with high metastasis potential; we further studied serum CK19 fragment CYFRA 21-1 level in HCC patients and nude mice model of HCC metastasis. HCC cell line HCCLM3 was injected subcutaneously into 30 nude mice which were then randomized into 6 groups of 5 mice each. The murine serum CYFRA 21-1 and pulmonary metastases were determined 2, 3, 4, 5, 6, and 7 weeks after injection. Serum CYFRA 21-1 levels of 101 normal controls and 108 HCC patients were also determined. In nude mice model, CYFRA 21-1 level increased significantly when pulmonary metastases occurred. Among 108 HCC patients, 24 (22.2%) had increased serum CYFRA 21-1 level. The presence of portal vein tumor emboli was significantly higher in CYFRA 21-1 increased cases (33.3%, 6/24) than in CYFRA 21-1 normal cases (6.0%, 5/84) (x(2)=7.403, P < 0.01). In addition, the percentage of TNM stage III/IV tumor was significantly higher in CYFRA 21-1 increased patients (54.2%, 13/24) than in CYFRA 21-1 normal cases (21.4%, 18/84) (x(2)=9.776, P < 0.005). These results suggest that CK19 may play an important role in HCC metastasis.
-
Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment
Renhou Zhi,Pengfei Hao,Weibin Li,Haoliang Zhao
DOI: https://doi.org/10.2147/jhc.s427624
2023-10-10
Journal of Hepatocellular Carcinoma
Abstract:Renhou Zhi, Pengfei Hao, Weibin Li, Haoliang Zhao Department of General Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, People's Republic of China Correspondence: Haoliang Zhao, Department of General Surgery, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, No. 99 Longcheng Street, Xiaodian District, Taiyuan, 030032, People's Republic of China, Tel +86 138 0340 0588, Email Purpose: Cyclin-dependent kinase regulatory subunit 2 (CKS2) has an important function in regulating cancer progression and cell cycle. This research aims to ascertain how CKS2 plays its part through multi-omics analyses, to reveal its relationship with the immune microenvironment in hepatocellular carcinoma (HCC). Material and Methods: Multiple databases were used to determine the transcriptional data of CKS2, epigenetic changes, and effects thereof upon the prognosis of HCC patients. The biological functions of CKS2 in HCC were expounded by functional enrichment analysis. TIMER, GSEA, TIP, and online single-cell sequencing databases were adopted for revealing correlations of CKS2 expression with infiltration of immune cells, immunomodulators, immunity cycle, and immune markers in the immune microenvironment of HCC. In addition, qRT-PCR and Western blot were used to validate gene expression in tissues from HCC patients. Results: Open database analysis confirmed that CKS2 is highly expressed in HCC and that it is related to poor prognosis in HCC patients. Aberrant methylation levels of the two methylation sites of CKS2 in HCC contributed to its high expression and were correlated significantly with survival. The CKS2 expression was positively correlated with most immunomodulators and infiltration levels for B and CD8+T cells, dendritic cells, and macrophages, especially exhausted CD8+T cells. Besides, the CKS2 expression was also found to have significant correlations with immunity cycle steps and diverse immune markers in HCC. The high CKS2 expression was confirmed in HCC at both mRNA and protein levels, showing a significant increase compared to normal tissue. Conclusion: CKS2 is a potential prognostic biomarker of HCC and can promote the progression of HCC via its influences on the immune environment. Additionally, a positive correlation between CKS2 and immune markers was observed, highlighting its potential as an immunotherapeutic target. Keywords: hepatocellular carcinoma, CKS2, tumor immune microenvironment, immune cycle, immune markers, immunomodulators Hepatocellular carcinoma (HCC), accounting for 75–85% of all primary liver cancers, is the sixth most commonly diagnosed cancer. 1,2 In recent years, it has been reported that the morbidity and mortality of liver cancer continue to rise, accompanied by a low five-year relative survival rate. 3 Risks of cancer mainly include hepatitis B or C viral infection, alcoholism, non-alcoholic fatty liver disease, obesity, and metabolic syndrome. 4 Only a small number of patients with early liver cancer benefit from radical treatment, including resection, local ablation, or liver transplantation. 5 For advanced patients, although significant progress has been achieved in multimodal therapy, including radiotherapy, chemotherapy, and targeted therapy, 6–11 the prognosis remains far from satisfactory. Notably, the latest research indicates the potential for immunotherapy as a cure for HCC in the future, 12 and in particular, a revolutionary breakthrough has been obtained for immune-checkpoint inhibitors in the treatment of HCC. 13 However, most patients did not respond well to this treatment. 14 The phenomenon has kindled our interest in studying the underlying molecular mechanism that regulates tumor immunotherapy responses and immune microenvironments. Therefore, searching for new prognostic biomarkers and underlying targets for immune-related therapy is important. The cyclin-dependent kinase regulatory subunit (CKS) family consists of two members: CKS1 and CKS2. They are members of highly conserved small (9 KDa) cyclin-dependent kinase (CDK)-binding proteins which are indispensable components in cell cycle regulation. 15,16 Growing evidence has shown the over-expression of CKS2 in diverse tumors, such as colon, breast, and cholangiocarcinoma, 17–19 and the involvement of CKS2 in the progression of tumors. Furthermore, it has been shown that the high expression of this gene in adrenocortical carcinoma and lung adenocarcinoma not only accelerates tumor growth, but also influences immune infiltration and controls the immune m -Abstract Truncated-
oncology
-
Gene Expression Profile of Human Hepatocellular Carcinoma Cell Lines with Different Metastatic Potentials
Yan Li,Zhaoyou Tang,Shenglong Ye,Binbin Liu,Yinkun Liu,Jie Chen,Qiong Xue
DOI: https://doi.org/10.3760/j.issn:0253-3766.2002.06.004
2002-01-01
Abstract:OBJECTIVE:To compare gene expression profile of human hepatocellular carcinoma (HCC) cell lines with different metastatic potentials, so as to screen for metastasis-related genes.METHODS:Gene expression profile of MHCC97-L and HCCLM3, two HCC cell lines with similar genetic background but different in spontaneous metastatic potentials, were studied by cDNA microarray.RESULTS:From 1,626 screened genes, 25 differentially expressed genes were found, 18 showed decreased expression including the decreased expression of cell cycle control genes Rb2, mismatch repair gene hMSH2, and signal transduction gene protein kinase C beta 2 and 7 increased expression including signal transduction gene MAP kinase kinase 6, cell proliferation gene E25, immunity related gene SP40, 40, etc in HCCLM3.CONCLUSION:The genes, being closely associated with cancer metastasis, could be considered as potential markers to predict metastasis and targets for anti-metastasis intervention.
-
Epithelial|[ndash]|mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
Y-M Li,S-C Xu,jingxia li,K-Q Han,H-F Pi,liang zheng,G-H Zuo,X-B Huang,H-Y Li,H-Z Zhao,Z-P Yu,Z Zhou,ping liang
DOI: https://doi.org/10.1038/cddis.2013.347
2013-01-01
Cell Death and Disease
Abstract:The presence of circulating tumor cells (CTCs) in peripheral blood is associated with metastasis and prognosis in hepatocellular carcinoma (HCC) patients. The epithelial–mesenchymal transition (EMT) has a pivotal role in tumor invasion and dissemination. To identify more sensitive biomarkers for evaluating metastasis and prognosis, we investigated the expression of EMT markers, including vimentin, twist, ZEB1, ZEB2, snail, slug and E-cadherin in CTCs, primary HCC tumors and adjacent non-tumoral liver tissues. After isolating viable CTCs from the peripheral blood of HCC patients using asialoglycoprotein receptors (ASGPRs), the CTCs were identified with immunofluorescence staining. CTCs were detected in the peripheral blood obtained from 46 of 60 (76.7%) HCC patients. Triple-immunofluorescence staining showed that twist and vimentin expression could be detected in CTCs obtained from 39 (84.8%) and 37 (80.4%) of the 46 patients, respectively. The expression of both twist and vimentin in CTCs was significantly correlated with portal vein tumor thrombus. Coexpression of twist and vimentin in CTCs could be detected in 32 (69.6%) of the 46 patients and was highly correlated with portal vein tumor thrombus, TNM classification and tumor size. Quantitative fluorescence western blot analysis revealed that the expression levels of E-cadherin, vimentin and twist in HCC tumors were significantly associated with the positivity of isolated CTCs (P=0.013, P=0.012, P=0.009, respectively). However, there was no significant difference in ZEB1, ZEB2, snail and slug expression levels in CTCs, primary HCC tumors and adjacent non-tumoral liver tissues across samples with regard to the clinicopathological parameters. Our results demonstrate that the EMT has a role in promoting the blood-borne dissemination of primary HCC cells, and the twist and vimentin expression levels in CTCs could serve as promising biomarkers for evaluating metastasis and prognosis in HCC patients.
-
Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro
Cui Jiefeng,Liu Yinkun
DOI: https://doi.org/10.1002/pmic.200500460
2006-01-01
PROTEOMICS
Abstract:Widespread metastasis of hepatocellular carcinoma (HCC) was a complex cascade of events, which is still beyond full appreciation. Screening key proteins, which play a critical role in metastasis, using high-throughput proteomics approach help discover valuable biomarkers and elucidate the mechanism of metastasis. This study was to find out some metastasis candidate proteins among HCC cell lines with various metastatic potential by comparative proteomics, and then further validate the biological function of these proteins in metastasis in vitro. The protein profiles of metastatic HCC cell lines (MHCC97H and MHCC97L) displayed obvious differences compared with nonmetastatic ones (Hep3B). Twenty-six metastasis candidate proteins, which were identified by on-line LC-ESI-MS/MS, such as S100 calcium-binding protein A4 (S100A4), annexin 1, etc., might have much application in diagnostic procedures and prognosis evaluation. S100A4, as a leading different metastasis candidate protein, which overexpressed only in the metastatic cells, was selected for further investigation. A series of assays related to invasion and metastasis in vitro, including cell motility, invasion, and matrix metalloproteinases (MMPs) secretion, were performed in MHCC97H/antisense recombinant plasmid to S100A4 (pcDNA3.1(+) AS S100A4) and the mock controls. All the data in the present study suggested that S100A4 might contribute to HCC invasion and metastasis through two paths of matrix metalloproteinase (MMP9) secretion regulation and strengthened motility and invasion properties.
-
Comprehensive Profiling of Metastasis-Related Proteins in Paired Hepatocellular Carcinoma Cells with Different Metastasis Potentials
Peiming Song,Huimin Bao,Yanbao Yu,Yan Xue,Dong Yun,Yang Zhang,Yufei He,Yinkun Liu,Qingping Liu,Haojie Lu,Huizhi Fan,Jianhua Luo,Pengyuan Yang,Xian Chen
DOI: https://doi.org/10.1002/prca.200780131
2009-01-01
PROTEOMICS - CLINICAL APPLICATIONS
Abstract:Precise and comprehensive identifications of the proteins associated with metastasis are critical for early diagnosis and therapeutic intervention of hepatocellular carcinoma (HCC). Therefore, we investigated the proteomic differences between a pair of HCC cell lines, originating from the same progenitor, with different metastasis potential using amino acid-coded mass tagging-based LC-MS/MS quantitative proteomic approach. Totally the relative abundance of 336 proteins in these cell lines were quantified, in which 121 proteins were upregulated by >30%, and 64 proteins were downregulated by >23% in the cells with high metastasis potential. Further validation studies by Western blotting in a series of HCC cell types with progressively increasing trend of metastasis showed that peroxiredoxin 4, HSP90β and HSP27 were positively correlated with increasing metastasis while prohibitin was negatively correlated with metastasis potential. These validation results were also consistent with that obtained from comparative analysis of clinic tissues samples. Function annotations of differentially expressed HCC proteome suggested that the emergence and development of high metastasis involved the dysregulation of cell migration, cell cycle and membrane traffics. Together our results revealed a much more comprehensive profile than that from 2-DE-based method and provided more global insights into the mechanisms of HCC metastasis and potential markers for clinical diagnosis.
-
Epithelial–mesenchymal Transition Markers Expressed in Circulating Tumor Cells in Hepatocellular Carcinoma Patients with Different Stages of Disease
Y-M Li,S-C Xu,J Li,K-Q Han,H-F Pi,L Zheng,G-H Zuo,X-B Huang,H-Y Li,H-Z Zhao,Z-P Yu,Z Zhou,P Liang
DOI: https://doi.org/10.1038/cddis.2013.347
2013-01-01
Cell Death and Disease
Abstract:The presence of circulating tumor cells (CTCs) in peripheral blood is associated with metastasis and prognosis in hepatocellular carcinoma (HCC) patients. The epithelial-mesenchymal transition (EMT) has a pivotal role in tumor invasion and dissemination. To identify more sensitive biomarkers for evaluating metastasis and prognosis, we investigated the expression of EMT markers, including vimentin, twist, ZEB1, ZEB2, snail, slug and E-cadherin in CTCs, primary HCC tumors and adjacent non-tumoral liver tissues. After isolating viable CTCs from the peripheral blood of HCC patients using asialoglycoprotein receptors (ASGPRs), the CTCs were identified with immunofluorescence staining. CTCs were detected in the peripheral blood obtained from 46 of 60 (76.7%) HCC patients. Triple-immunofluorescence staining showed that twist and vimentin expression could be detected in CTCs obtained from 39 (84.8%) and 37 (80.4%) of the 46 patients, respectively. The expression of both twist and vimentin in CTCs was significantly correlated with portal vein tumor thrombus. Coexpression of twist and vimentin in CTCs could be detected in 32 (69.6%) of the 46 patients and was highly correlated with portal vein tumor thrombus, TNM classification and tumor size. Quantitative fluorescence western blot analysis revealed that the expression levels of E-cadherin, vimentin and twist in HCC tumors were significantly associated with the positivity of isolated CTCs (P=0.013, P=0.012, P=0.009, respectively). However, there was no significant difference in ZEB1, ZEB2, snail and slug expression levels in CTCs, primary HCC tumors and adjacent non-tumoral liver tissues across samples with regard to the clinicopathological parameters. Our results demonstrate that the EMT has a role in promoting the blood-borne dissemination of primary HCC cells, and the twist and vimentin expression levels in CTCs could serve as promising biomarkers for evaluating metastasis and prognosis in HCC patients.